Paederosidic acid

Paederosidic acid
Product Name Paederosidic acid
CAS No.: 18842-98-3
Catalog No.: CFN92524
Molecular Formula: C18H24O12S
Molecular Weight: 464.4 g/mol
Purity: >=98%
Type of Compound: Iridoids
Physical Desc.: Powder
Targets: Bcl-2/Bax | Caspase | Akt | JNK | GABA Receptor
Source: The herbs of Paederia scandens (Lour.) Merr
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $108/20mg
Paederosidic acid has significant anti-tumor, anticonvulsant and sedative effects. Paederosidic acid increases brain gamma-aminobutyric acid and decreases glutamic acid in the brain, and it up-regulates expressions of GAD 65, may be a promising future therapeutic agent for treatment of epilepsy.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Konkuk University2023, 29:4634721
  • Arch Biochem Biophys.2020, 687:108363.
  • Planta Med.2022, a-1876-3009.
  • J Pain Res.2022, 15:3469-3478.
  • Hum Exp Toxicol.2023, 42:9603271221145386.
  • Food Res Int.2022, 157:111397.
  • Phytomedicine.2019, 57:95-104
  • Fitoterapia.2024, 175:105955.
  • Environ Toxicol.2021, 36(9):1848-1856.
  • Sains Malaysiana2024, 53(2):397-408.
  • Euphroside

    Catalog No: CFN96341
    CAS No: 76994-07-5
    Price: Inquiry(manager@chemfaces.com)
    8-Epideoxyloganic acid

    Catalog No: CFN96280
    CAS No: 88668-99-9
    Price: $168/20mg
    8-Dehydroxy shanzhiside

    Catalog No: CFN91607
    CAS No: 1008532-71-5
    Price: Inquiry(manager@chemfaces.com)
    Loganic acid

    Catalog No: CFN98212
    CAS No: 22255-40-9
    Price: $50/20mg
    Alboside I

    Catalog No: CFN95752
    CAS No: 239791-85-6
    Price: $318/10mg
    Gentiournoside D

    Catalog No: CFN90979
    CAS No: 157722-21-9
    Price: $388/5mg
    Mussaenosidic acid

    Catalog No: CFN91394
    CAS No: 82451-22-7
    Price: Inquiry(manager@chemfaces.com)
    Shanzhiside

    Catalog No: CFN98370
    CAS No: 29836-27-9
    Price: $318/20mg
    Negundoside

    Catalog No: CFN70455
    CAS No: 82451-20-5
    Price: Inquiry(manager@chemfaces.com)
    Monotropein

    Catalog No: CFN99523
    CAS No: 5945-50-6
    Price: $90/20mg
    Chem Biol Interact. 2017 May 1;269:33-40.
    Antitumor activity of paederosidic acid in human non-small cell lung cancer cells via inducing mitochondria-mediated apoptosis.[Pubmed: 28185768]
    This study was aimed to investigate antitumor activity of Paederosidic acid (PA) in human non-small cell lung cancer cells and explore the related mechanisms.
    METHODS AND RESULTS:
    The anti-proliferative effects of PA on A549 cells were evaluated by MTT method and the IC50 values were calculated. Furthermore, the PA-induced apoptosis in A549 cells was determined by fluorescence microscope via staining with DAPI and by flow cytometer via staining with FITC conjugated Annexin V/PI. The expression of apoptosis-related or signaling proteins was investigated by Western blotting. Our results demonstrated that PA showed significant anti-tumor activity on lung cancer in vitro; the mechanisms were involved in inducing mitochondria-mediated apoptosis via up-regulation of caspase-3, caspase-8, caspase-9, Bid, Bax, down-regulation of Bcl-2 and stimulating the release of Cyto-C from mitochondria. In addition, JNK phosphorylation levels significantly increased concomitantly with decrease in Akt phosphorylation after treatment with PA in A549 cells. However, JNK siRNA-transfected cells diminished PA-induced caspase-3, 8 and 9, Bid and Bax activaton while enhanced the Bcl-2 activation.
    CONCLUSIONS:
    Collectively, these results indicated that PA-induced JNK activation played an important functional role in apoptosis.
    Pharmacol Biochem Behav. 2013 Oct;111:97-101.
    Anticonvulsant and sedative effects of paederosidic acid isolated from Paederia scandens (Lour.) Merrill. in mice and rats.[Pubmed: 24029464]
    This study was designed to evaluate the anticonvulsant and sedative effects of Paederosidic acid isolated from Paederia scandens (Lour.) Merrill. in mice and rats.
    METHODS AND RESULTS:
    In the present study, anticonvulsant activities of Paederosidic acid were evaluated by maximal electroshock and pentylenetetrazole-induced seizures in male mice. Then, pentobarbital sodium-induced sleeping time and locomotor activity tests in mice were used to evaluate the sedative effects of Paederosidic acid. Finally, the mechanism of Paederosidic acid was explored by evaluating the contents of Glu and GABA in the brain, and Western blot was used to measure GAD65 expression in the mouse brain. Paederosidic acid (5, 10, 20, and 40 mg/kg, ip) had significant anticonvulsant and sedative effects. Moreover, Paederosidic acid increased brain gamma-aminobutyric acid and decreased glutamic acid in the brain, and it up-regulated expressions of GAD 65.
    CONCLUSIONS:
    In conclusion, our results suggest that Paederosidic acid may be a promising future therapeutic agent for treatment of epilepsy.
    Gymnoside III

    Catalog No: CFN95033
    CAS No: 899430-03-6
    Price: $238/10mg
    Methyl lucidenate G

    Catalog No: CFN95058
    CAS No: 102607-20-5
    Price: $413/5mg
    Yuanhuanin

    Catalog No: CFN95127
    CAS No: 83133-14-6
    Price: $318/5mg
    Orientalide

    Catalog No: CFN95136
    CAS No: 72704-05-3
    Price: $368/5mg
    Puerol B

    Catalog No: CFN95155
    CAS No: 112343-17-6
    Price: $398/5mg
    (R)-O-isobutyroyllomatin

    Catalog No: CFN95250
    CAS No: 440094-38-2
    Price: $318/5mg
    9-Octadecenedioic acid

    Catalog No: CFN95301
    CAS No: 4494-16-0
    Price: $100/20mg
    3',4',5',5,7-Pentamethoxyflavanone

    Catalog No: CFN95414
    CAS No: 479672-30-5
    Price: $218/20mg
    Erythro-Guaiacylglycerol-beta-coniferyl aldehyde ether

    Catalog No: CFN95416
    CAS No: 74474-55-8
    Price: $318/5mg
    Hosenkoside D

    Catalog No: CFN95521
    CAS No: 156823-94-8
    Price: $318/5mg